Sleep duration and sarcopenia in adults aged = 65 years from low and middle-income countries.
Por:
Smith L, Shin JI, Veronese N, Soysal P, López Sánchez GF, Pizzol D, Demurtas J, Tully MA, Barnett Y, Butler L and Koyanagi A
Publicada:
1 jul 2022
Ahead of Print:
1 feb 2022
Resumen:
BACKGROUND: Sleep duration may influence risk for sarcopenia but studies on this topic are scarce, especially from low and- middle-income countries (LMICs). Thus, the aim of the present study was to investigate the association between sleep duration and sarcopenia among adults aged = 65 years from five LMICs (China, Ghana, India, Russia, South Africa). METHODS: Cross-sectional, community-based data from the WHO study on global ageing and adult health (SAGE) were analysed. Sarcopenia was defined as having low skeletal muscle mass (SMM) and weak handgrip strength, while severe sarcopenia was defined as having low SMM, weak handgrip strength, and slow gait speed. Self-reported sleep duration in the past two nights were averaged and classified as = 6, > 6 to = 9, and = 9 h/day. Multivariable logistic regression analysis was conducted. RESULTS: Data on 13,210 adults aged = 65 years [mean (SD) age 72.6 (11.3) years; 55.0% females] were analyzed. In the overall sample, compared to > 6 to = 9 h/day of sleep duration, > 9 h/day was associated with 1.70 (95% CI 1.15-2.51) and 1.75 (95% CI 1.08-2.84) times higher odds for sarcopenia and severe sarcopenia, respectively. No significant associations were observed among males, but associations were particularly pronounced among females [i.e., OR = 2.19 (95% CI 1.26-3.81) for sarcopenia, and OR = 2.26 (95% CI 1.20-4.23) for severe sarcopenia]. CONCLUSIONS: Long sleep duration was associated with an increased odds of sarcopenia and severe sarcopenia in LMICs, particularly in females. Future studies should investigate whether addressing long sleep duration among females can lead to lower risk for sarcopenia onset in LMICs.
Filiaciones:
Smith L:
Centre for Health, Performand and Wellbeing, Anglia Ruskin University, Cambridge, CB1 1PT, UK
Shin JI:
Department of Pediatrics, Yonsei University College of Medicine, Yonsei-ro 50, Seodaemun-gu, 8044, Seoul, 120-752, Republic of Korea
Veronese N:
Department of Internal Medicine, Geriatrics Section, University of Palermo, Palermo, Italy
Soysal P:
Department of Geriatric Medicine, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey
López Sánchez GF:
Division of Preventive Medicine and Public Health, Department of Public Health Sciences, School of Medicine, University of Murcia, 30100, Murcia, Espinardo, Spain.
Pizzol D:
Italian Agency for Development Cooperation, Jerusalem, Israel
Demurtas J:
Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy
Tully MA:
Institute of Mental Health Sciences, School of Health Sciences, Ulster University, Newtownabbey, BT15 1ED, Northern Ireland
Barnett Y:
Centre for Health, Performand and Wellbeing, Anglia Ruskin University, Cambridge, CB1 1PT, UK
Butler L:
Centre for Health, Performand and Wellbeing, Anglia Ruskin University, Cambridge, CB1 1PT, UK
Koyanagi A:
Research and Development Unit, Parc Sanitari Sant Joan de Déu, CIBERSAM, Dr. Antoni Pujadas, 42, Sant Boi de Llobregat, 08830, Barcelona, Spain
ICREA, Pg, Lluis Companys 23, 08010, Barcelona, Spain
Green Submitted, Green Accepted
|